Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial (Q33378523)

26 July 2017

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial (English)

1 reference

Immune thrombocytopenic purpura

26 July 2017

1 reference

1 reference

1 reference

Miguel A Sanz

10

0 references

James Bruce Bussel

2

object named as

James B Bussel

1 reference

26 July 2017

26

Ronald S Go

1 reference

26 July 2017

16

Adrian Newland

1 reference

26 July 2017

David J Kuter

1

1 reference

26 July 2017

Roger M Lyons

3

1 reference

26 July 2017

Vinod Pullarkat

4

1 reference

26 July 2017

Terry B Gernsheimer

5

1 reference

26 July 2017

Francis M Senecal

6

1 reference

26 July 2017

Louis M Aledort

7

1 reference

26 July 2017

James N George

8

1 reference

26 July 2017

Craig M Kessler

9

1 reference

26 July 2017

Howard A Liebman

11

1 reference

26 July 2017

Frank T Slovick

12

1 reference

26 July 2017

J Th M de Wolf

13

1 reference

26 July 2017

Emmanuelle Bourgeois

14

1 reference

26 July 2017

Troy H Guthrie

15

1 reference

26 July 2017

Jeffrey S Wasser

17

1 reference

26 July 2017

Solomon I Hamburg

18

1 reference

26 July 2017

Carlos Grande

19

1 reference

26 July 2017

François Lefrère

20

1 reference

26 July 2017

Alan Eli Lichtin

21

1 reference

26 July 2017

Michael D Tarantino

22

1 reference

26 July 2017

Howard R Terebelo

23

1 reference

26 July 2017

Jean-François Viallard

24

1 reference

26 July 2017

Francis J Cuevas

25

1 reference

26 July 2017

David H Henry

27

1 reference

26 July 2017

Robert L Redner

28

1 reference

26 July 2017

Lawrence Rice

29

1 reference

26 July 2017

Martin R Schipperus

30

1 reference

26 July 2017

D Matthew Guo

31

1 reference

26 July 2017

Janet L Nichol

32

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

26 July 2017

1 reference

26 July 2017

371

1 reference

26 July 2017

395-403

1 reference

26 July 2017

9610

1 reference

Chronic idiopathic thrombocytopenic purpura

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Autoimmune Platelet Destruction: Idiopathic Thrombocytopenic Purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

How I treat idiopathic thrombocytopenic purpura (ITP).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Autoimmune (idiopathic) thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Management of patients with chronic, refractory idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Treatment options for chronic idiopathic (immune) thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Circulating thrombopoietin level in chronic immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Serum thrombopoietin level in various hematological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

New thrombopoietic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

A Survey of Exact Inference for Contingency Tables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

High-dose intravenous IgG in adults with autoimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Very low dose danazol in idiopathic thrombocytopenic purpura and its role as an immune modulator.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Idiopathic cyclic thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960203-2

7 January 2021

10.1016/S0140-6736(08)60203-2

Identifiers

DOI

1 reference

26 July 2017

1 reference